Interindividual differences in 2H8-toluene toxicokinetics assessed by a semiempirical physiologically based model

Toxicology and Applied Pharmacology

Volumn 139, Issue 1, 1996, Pages 49-61

  Pierce, Crispin H ^a   Dills, Russell L ^a   Morgan, Michael S ^a   Nothstein, Greg L ^a   Shen, Danny D ^a   Kalman, David A ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TOLUENE;

ADULT; AGE; ARTICLE; BODY WEIGHT; HUMAN; HUMAN EXPERIMENT; INHALATION; MODEL; NORMAL HUMAN; TOXICOKINETICS; ABSORPTION; ADIPOSE TISSUE; AGING; BIOLOGICAL MODEL; COMPUTER SIMULATION; ENVIRONMENTAL EXPOSURE; ISOTOPE LABELING; LIVER; LIVER CIRCULATION; LUNG; LUNG GAS EXCHANGE; LUNG VENTILATION PERFUSION RATIO; MALE; METABOLISM; MIDDLE AGED; PHYSIOLOGY; STATISTICAL MODEL; VASCULARIZATION;

ANIMALIA;

ABSORPTION; ADIPOSE TISSUE; ADULT; AGING; BLOOD-AIR BARRIER; BODY WEIGHT; COMPUTER SIMULATION; ENVIRONMENTAL EXPOSURE; HUMANS; ISOTOPE LABELING; LINEAR MODELS; LIVER; LIVER CIRCULATION; LUNG; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; TOLUENE; VENTILATION-PERFUSION RATIO;

EID: 0030176927     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1996.0142     Document Type: Article

References (79)

1. Andersen, M. E., Clewell, H. J., III, Gargas, M. L., Smith, F. A., and Reitz, R. H. (1987a). Physiologically based pharmacokinetics and the risk assessment process for methylene chloride. Toxicol. Appl. Pharmacol. 87, 185-205.
2. Andersen, M. E., MacNaughton, M. G., Clewell, H. J., III, and Paustenbach, D. J. (1987b). Adjusting exposure limits for long and short exposure periods using a physiological pharmacokinetic model. Am. Ind. Hyg. Assoc. J. 48, 335-343.
3. Angelo, M. J., and Pritchard, A. B. (1987). Route-to-route extrapolation of dichloromethane exposure using a physiological pharmacokinetic model. In Pharmacokinetics in Risk Assessment, pp. 254-264. National Academy Press, Washington, DC.
4. Ashley, D., Bonin, M., Cardinali, F., McCraw, J., and Wooten, J. (1994). Blood concentrations of volatile organic compounds in a nonoccupationally exposed U.S. population and in groups with suspected exposure. Clin. Chem. 40, 1401-1404.
5. Åstrand, P.-O., and Rodahl, K. (1986). Textbook of Work Physiology: Physiological Bases of Exercise, 3rd ed. McGraw-Hill, New York.
6. Bischoff, K. (1987). Physiologically based pharmacokinetic modeling. In Pharmacokinetics in Risk Assessment, pp. 36-61. National Academy Press, Washington, DC.
7. Bois, F., Krowech, G., and Zeise, L. (1995). Modeling human interindividual variability in metabolism and risk: The example of 4-aminobiphenyl. Risk Anal. 15, 205-213.
8. Brugnone, F., Gobbi, M., Ayyad, K., Giuliari, C., Cerpelloni, M., and Perbellini, L. (1995). Blood toluene as a biological index of environmental toluene exposure in the "normal" population and in occupationally exposed workers immediately after exposure and 16 hours later. Int. Arch. Occup. Environ. Health 66, 421-425.
9. Brugnone, F., Perbellini, L., Faccini, G. B., Pasini, F., Maranelli, G., Romeo, L., Gobbi, M., and Zedde, A. (1989). Breath and blood levels of benzene, toluene, cumene and styrene in non-occupational exposure. Int. Arch. Occup. Environ. Health 61, 303-311.
10. Bulow, J. (1981). Human adipose tissue blood flow during prolonged exercise. III. Effect of β-adrenergic blockade, nicotinic acid and glucose infusion. Scand. J. Clin. Lab. Invest. 41, 415-424.
11. Bulow, J., and Madsen, J. (1976). Adipose tissue blood flow during prolonged heavy exercise. Pflügers Arch. 363, 231-234.
12. Carlisle, K. M., Halliwell, M., Read, A. E., and Wells, P. N. T. (1992). Estimation of total hepatic blood flow by duplex ultrasound. Gut 33, 92-97.
13. Carlsson, A., and Ljungquist, E. (1982). Exposure to toluene: Concentration in subcutaneous adipose tissue. Scand. J. Work Environ. Health 8, 56-62.
14. Clewell, H. J., III, and Andersen, M. E. (1987). Dose, species, and route extrapolation using physiologically based pharmacokinetic models. In Pharmacokinetics in Risk Assessment, pp. 159-182. National Academy Press, Washington, DC.
15. Cohn, M. S. (1987). Sensitivity analysis in pharmacokinetic modeling. In Pharmacokinetics in Risk Assessment, pp. 265-272. National Academy Press, Washington, DC.
16. D'Sousa, R., and Boxenbaum, H. (1988). Physiological pharmacokinetic models: Some aspects of theory, practice and potential. Toxicol. Ind. Health 4, 151-171.
17. D'Souza, R. W., Francis, W. R., Bruce, R. D., and Andersen, M. E. (1987). Physiologically based pharmacokinetic model for ethylene dichloride and its application in risk assessment. In Pharmacokinetics in Risk Assessment, pp. 286-301. National Academy Press, Washington, DC.
18. Davies, B., and Morris, T. (1993). Physiological parameters in laboratory animals and humans. Pharmacol. Res. 10, 1093-1095.
19. Davis, N. R., and Mapleson, W. W. (1993). A physiological model for the distribution of injected agents, with special reference to pethidine. Br. J. Anaesth. 70, 248-258.
20. Dees, J. H., Masters, B. S., Muller-Eberhard, U., and Johnson, E. F. (1982). Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin and phenobarbital on the occurrence and distribution of four cytochrome P-450 isozymes in rabbit kidney, lung, and liver. Cancer Res. 42, 1423-1432.
21. Diem, K. (Ed.) (1962). Documenta Geigy: Scientific Tables, 6th ed. Geigy Pharmaceuticals, Ardsley, NY.
22. Dills, R. L., Ackerlund, W. S., Kalman, D. A., and Morgan, M. S. (1994). Inter-individual variability in blood/air partitioning of volatile organic compounds and correlation with blood chemistry. J. Expo. Anal. Environ. Epidemiol. 4, 229-244.
23. Dills, R. L., Kent, S. D., Checkoway, H., and Kalman, D. A. (1991). Quantification of volatile solvents in blood by static headspace analysis. Talanta 38, 365-374.
24. Dunker, A. (1984). The decoupled-direct method for calculating sensitivity coefficients in chemical kinetics. J. Chem. Phys. 81, 2085-2093.
25. Durnin, J. V., and Womersley, J. (1974). Body fat assessed from total body density and its estimation from skin fold thickness: Measurements on 481 men and women aged from 16 to 72 years. Br. J. Nutr. 32, 77-97.
26. Engfeldt, P., and Linde, B. (1992). Subcutaneous adipose tissue blood flow in the abdominal and femoral regions in obese women: Effect of fasting. Int. J. Obes. 16, 875-879.
27. Etzel, R., and Ashley, D. (1994). Volatile organic compounds in the blood of persons in Kuwait during the oil fires. Int. Arch. Occup. Environ. Health 66, 125-129.
28. Ferrannini, E. (1992). The haemodynamics of obesity: A theoretical analysis. J. Hypertens. 10, 1417-1423.
29. Fustinoni, S., Buratti, M., Giampiccolo, R., and Colombi, A. (1995). Biological and environmental monitoring of exposure to airborne benzene and other aromatic hydrocarbons in Milan traffic wardens. Toxicol. Lett. 77, 387-392.
30. Gargas, M. L., Burgess, R. J., Voisard, D. E., Cason, G. H., and Andersen, M. E. (1989). Partition coefficients of low-molecular-weight volatile chemicals in various liquids and tissues. Toxicol. Appl. Pharmacol. 98, 87-99.
31. Gearhart, J., Mahle, D., Greene, R., Seckel, C., Flemming, C., Fisher, J., and Clewell, H., III (1993). Variability of physiologically based pharmacokinetic (PBPK) model parameters and their effects on PBPK model predictions in a risk assessment for perchloroethylene (PCE). Toxicol. Lett. 68, 131-144.
32. Girardin, E., and Bruguerolle, B. (1993). Pharmacokinetic changes in obesity. Therapie 48, 397-402.
33. Gut, I., Terelius, Y., Frantík, E., Linhart, I., Soucek, P., Filipcová, B., and Klucková, H. (1993). Exposure to various benzene derivatives differently induces cytochromes P450 2B1 and P450 2E1 in rat liver. Arch. Toxicol. 67, 237-243.
34. Hall, P. de la M., Stupans, I., Burgess, W., Birkett, D. J., and McManus, M. E. (1989). Immunohistochemical localization of NADPH-cytochrome P450 reductase in human tissues. Carcinogenesis 10, 521-530.
35. Hetrick, D. M., Jarabek, A. M., and Travis, C. C. (1991). Sensitivity analysis for physiologically based pharmacokinetic models. J. Pharmacokinet. Biopharm. 19, 1-20.
36. Ings, R. (1990). Interspecies scaling and comparisons in drug development and toxicokinetics. Xenobiotica 20, 1201-1231.
37. Inoue, O., Seiji, K., Watanabe, T., Kasahara, M., Nakatsuka, H., Yin, S. N., Li, G. L., Cai, S. X., Jin, C., and Ikeda, M. (1988). Mutual metabolic suppression between benzene and toluene in man. Int. Arch. Occup. Environ. Health 60, 15-20.
38. Inoue, O., Seiji, K., Watanabe, T., Kasahara, M., Nakatsuka, H., Yin, S., Li, G., Cai, S., Jin, C., and Ikeda, M. (1986). Possible ethnic difference in toluene metabolism: Comparative study among Chinese, Turkish and Japanese solvent workers. Toxicol. Lett. 34, 167-174.
39. Katayama, M., Yamazumi, K., Kino, K., Tsuru, M., Fukazawa, T., and Shimada, H. (1990). Changes in liver weight in the elderly. Nippon Ron. Igak. Zas. 27, 584-588.
40. Kawai, T., Mizunuma, K., Yasugi, T., Horiguchi, S., and Ikeda, M. (1994). Toluene in blood as a marker of choice for low-level exposure to toluene. Int. Arch. Occup. Environ. Health 66, 309-315.
41. Kawai, T., Yasugi, T., Mizunuma, K., Horiguchi, S., Iguchi, H., Uchida, Y., Iwami, O., and Ikeda, M. (1992a). Comparative evaluation of urinalysis and blood analysis as means of detecting exposure to organic solvents at low concentrations. Int. Arch. Occup. Environ. Health 64, 223-234.
42. Kawai, T., Yasugi, T., Mizunuma, K., Horiguchi, S., and Ikeda, M. (1992b). Urinalysis vs blood analysis, as a tool for biological monitoring of solvent exposure. Toxicol. Lett. 63, 333-343.
43. Kawai, T., Yasugi, T., Mizunuma, K., Horiguchi, S., Morioka, I., Miyashita, K., Uchida, Y., and Ikeda, M. (1992c). Monitoring of workers exposed to a mixture of toluene, styrene and methanol vapours by means of diffusive air sampling, blood analysis and urinalysis. Int. Arch. Occup. Environ. Health 63, 429-435.
44. Larsen, O., Lassen, N., and Quaade, F. (1966). Blood flow through human adipose tissue determined with radioactive xenon. Acta Physiol. Scand. 66, 337-345.
45. Leggett, R. W., and Williams, L. B. (1991). Suggested reference values for regional blood volumes in humans. Health Phys. 60, 139-154.
46. Life Systems, Inc. (1994). Toxicological Profile for Toluene (Update), ATSDR/TP-93/14. U.S. Department of Health and Human Services, Public Health Service, Agency for Toxic Substances and Disease Registry, Atlanta, GA.
47. Ludden, T., Allerheiligen, S., and Burk, R. (1991). Application of population analysis to physiological pharmacokinetics. J. Pharmacokinet. Biopharm. 19, 101S-113S.
48. Lundbergh, P., and Strandell, T. (1974). Changes in hepatic circulation at rest, during and after exercise in young males with infectious hepatitis compared with controls. Acta Med. Scand. 196, 315-325.
49. Mannino, D., Schreiber, J., Aldous, K., Ashley, D., Moolenaar, R., and Almaguer, D. (1995). Human exposure to volatile organic compounds: A comparison of organic vapor monitoring badge levels with blood levels. Int. Arch. Occup. Environ. Health 67, 59-64.
50. Mordenti, J. (1986). Man versus beast: Pharmacokinetic scaling in mammals. J. Pharm. Sci. 75, 1028-1040.
51. Morgan, D., and Bray, K. (1994). Lean body mass as a predictor of drug dosage. Clin. Pharmacokinet. 26, 292-307.
52. Morgan, M. S., Dills, R. L., and Kalman, D. A. (1993). Evaluation of stable isotope-labeled probes in the study of solvent pharmacokinetics in human subjects. Int. Arch. Occup. Environ. Health 65, S139-S142.
53. Nakajima, T., Wang, R. S., Elovaara, E., Park, S. S., Gelboin, H. V., Hietanen, E., and Vainio, H. (1991). Monoclonal antibody-directed characterization of cytochrome P450 isozymes responsible for toluene metabolism in rat liver. Biochem. Pharmacol. 41, 395-404.
54. Nauck, M. A., Liess, H., Siegel, E. G., Niedmann, P. D., and Creutzfeldt, W. (1992). Critical evaluation of the "heated-hand-technique" for obtaining "arterialized" venous blood: Incomplete arterialization and alterations in glucagon responses. Clin. Physiol. 12, 537-552.
55. Nies, A. S., Shand, D. G., and Wilkinson, G. R. (1976). Altered hepatic blood flow and drug disposition. Clin. Pharmacokinet. 1, 135-155.
56. Nise, G., Attewell, R., Skerfving, S., and Ørbæk, P. (1989). Elimination of toluene from venous blood and adipose tissue after occupational exposure. Br. J. Ind. Med. 46, 407-411.
57. O'Flaherty, E. J. (1993). Physiologically based models for bone-seeking elements. IV. Kinetics of lead disposition in humans. Toxicol. Appl. Pharmacol. 118, 16-29.
58. Pierce, C. H., Dills, R. L., Silvey, G. W., and Kalman, D. A. (1995). Partition coefficients between human blood or adipose tissue and air for aromatic solvents. Scand. J. Work Environ. Health 22, in press.
59. Purcell, K. J., Cason, G. H., Gargas, M. L., Andersen, M. E., and Travis, C. C. (1990). In vivo metabolic interactions of benzene and toluene. Toxicol. Lett. 52, 141-152.
60. Ramsey, J. C., and Andersen, M. E. (1984). A physiologically based description of the inhalation pharmacokinetics of styrene in rats and humans. Toxicol. Appl. Pharmacol. 73, 159-175.
61. Ritschel, W., Vachharajani, N., Johnson, R., and Hussain, A. (1992). The allometric approach for interspecies scaling of pharmacokinetic parameters. Comp. Biochem. Physiol. 103C, 249-253.
62. Roth, R. A., and Vinegar, A. (1990). Action by the lungs on circulating xenobiotic agents, with a case study of physiologically based pharmacokinetic modeling of benzo(a)pyrene disposition. Pharmacol. Ther. 48, 143-145.
63. Rowland, M., and Tozer, T. N. (1989). Clinical Pharmacokinetics: Concepts and Applications, 2nd ed. Lea and Febiger, Philadelphia, PA.
64. Sato, A. (1988). Toxicokinetics of benzene, toluene and xylenes. IARC Sci. Publ. 85, 47-64.
65. Sato, A. (1991). The effect of environmental factors on the pharmacokinetic behaviour of organic solvent vapors. Ann. Occup. Hyg. 35, 525-541.
66. Sato, A., Endoh, K., Kaneko, T., and Johanson, G. (1991). A simulation study of physiological factors affecting pharmacokinetic behaviour of organic solvent vapours. Br. J. Ind. Med. 48, 342-347.
67. Sato, A., Nakajima, T., Fujiwara, Y., and Hirosawa, K. (1974). Pharmacokinetics of benzene and toluene. Int. Arch. Arbeitsmed. 33, 169-182.
68. Srbová, J., and Teisinger, J. (1952) Absorption and elimination of toluene in man. Pracov. Lék. 4, 41-47.
69. Tardif, R., Laparé, S., Krishnan, K., and Brodeur, J. (1993). Physiologically based modeling of the toxicokinetic interaction between toluene and m-xylene in the rat. Toxicol. Appl. Pharmacol. 120, 266-273.
70. Thomas, R. D. (1986). Drinking Water and Health, Vol. 6. National Academy Press, Washington, DC.
71. Thomas, R., Bigelow, P., Keefe, T., and Yang, R. (1996). Variability in biological exposure indices using physiologically based pharmacokinetic modeling and Monte Carlo simulation. Am. Ind. Hyg. Assoc. J. 57, 23-32.
72. Thummel, K. E., Kharasch, E. D., Podoll, T., and Kunze, K. (1993). Human liver microsomal enflurane defluorination catalyzed by cytochrome P-450 2E1. Drug Metab. Dispos. 21, 350-357.
73. U.S. Environmental Protection Agency (1993). Archive of human monitoring specimens: Disposition to private sector or other governmental party; notice of availability. Fed. Reg. 58, 60625-60628.
74. Veulemans, H., and Masschelein, R. (1978). Experimental human exposure to toluene. Int. Arch. Occup. Environ. Health 42, 105-117.
75. Vrca, A., Bozicevi'c, D., Karaci'c, V., Fuchs, R., Prpi'c-Maji'c, D., and Malinar, M. (1995). Visual evoked potentials in individuals exposed to long-term low concentrations of toluene. Arch. Toxicol. 69, 337-340.
76. Wallén, M. (1986). Toxicokinetics of toluene in occupationally exposed volunteers. Scand. J. Work Environ. Health 12, 588-593.
77. Wallén, M., Naslund, P., and Nordqvist, M. (1984). The effects of ethanol on the kinetics of toluene in man. Toxicol. Appl. Pharmacol. 76, 414-419.
78. Wheeler, C., Wrighton, S., and Guenthner, T. (1992). Detection of human lung cytochromes P450 that are immunochemically related to cytochrome P450IIE1 and cytochrome P450IIIA. Biochem. Pharmacol. 44, 183-186.
79. Woodhouse, K. W., and Wynne, H. A. (1988). Age-related changes in liver size and hepatic blood flow. Clin. Pharmacokinet. 15, 287-294.